why choose us

First received: July 11, 2023

Clinical Trial: Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Gastroenteritis

Study Type: INTERVENTIONAL


Official Title: Phase 2, Single-arm, Open-label Trial for Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of the Intramuscular HIL-214 Norovirus Vaccine in Adults Aged 18 to 49 Years

Brief Summary: The purpose of this trial is to obtain serum for proficiency testing to confirm assay validity is maintained following the dosing of adults with a pediatric dose of HIL-214.

Read more